Richard Augotoski

Richard Augotoski is a seasoned professional in business development within the life sciences and clinical research sectors, currently serving as a Senior Account Executive in Business Development for ICON plc since January 2021. With a robust background that includes leadership roles at QPS Holdings, INC Research, PRA Health Sciences, and Mapi Group, Richard has demonstrated expertise in managing complex projects and building client relationships. Richard's experience spans various aspects of drug and device development, focusing on real-world evidence and operational excellence to support clients in achieving their strategic goals. Educational credentials include attendance at Leeds Beckett University.